DoP lists options to rationalise drug trade margins for Niti Aayog

In a meeting held earlier this month with Niti Aayog, DoP also suggested that trade margin on all formulations and dosages be capped at 100%.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2mtwvvQ
via IFTTT